BIOCOM Investor Conference

October 26 – 28, 2008
Hyatt Regency La Jolla
3777 La Jolla Village Drive
San Diego, CA 92122

The third annual BIOCOM Investor Conference is a unique opportunity to gain access to leading technology from Southern California, one of the industry’s largest life science communities, with over 800 companies producing life saving technologies and products to improve quality of life for patients.  Highlighting investment opportunities, over 60 of these leading life science companies will present to principal institutional and private equity investors.  The conference will provide ample networking opportunities through plenary sessions, one-on-one meetings and company presentations.

Presenting Companies

The BIOCOM Investor Conference is a great opportunity for your company to showcase its business to a targeted audience of industry investors in a local setting and familiar environment.  We are now accepting applications to present. 

Please click here for the application and either email or fax completed form no later than September 1, 2008 to Valerie Sanderson at: vsanderson@biocom.org or fax: 858-455-0022.
Last year’s conference drew over 50 both public and private companies to present.  Please see below for a list of the 2007 presenting companies:

ACADIA Pharmaceuticals Adventrx Pharmaceuticals Aethlon Medical, Inc. Althea Technologies Ambit Biosciences AMN Healthcare Amylin Pharmaceuticals Anadys Pharmaceuticals Anaptys Arena Pharmaceuticals Inc. Artes Medical AviaraDx, Inc. BioAtom Inc. BioTechPlex   Cadence Pharmaceuticals  CalciMedica  Cardium Therapeutics  Cedar Therapeutics Inc.  Ceregene, Inc.

Cytori Therapeutics DermTech Digirad Dow BioPharma Favrille, Inc. GenProbe GlySens, Inc. Halozyme Hollis-Eden Pharmaceuticals Ichor IDM Pharma Inovio Biomedical Invitrogen Corporation ISIS Pharmaceuticals, Inc. Kemia Kinexis, Inc. Ligand Pharmaceuticals Lpath, Inc. Maven Biotechnologies, LLC

Metabasis Therapeutics, Inc. Mpex Pharmaceuticals NexBio NuVasive Nventa Biopharmaceutical Corp. Orexigen Therapeutics, Inc. Pharmexa-Epimmune PURE Biosciences Response Genetics Senomyx, Inc. SGX Pharmaceuticals Spectrum Pharmaceutical Inc. Tracon Pharmaceuticals Verus Pharmaceuticals Vical, Inc. Zacharon Pharmaceuticals Zogenix, Inc.

Lodging

If you require hotel accommodations during the conference please contact:
Hyatt Regency La Jolla
Hotel’s Reservations Department
1 (800) 233-1234 or (858) 552-1234

BIOCOM Special Discounted Rate is $199.00 plus all applicable taxes and charges.

The BIOCOM special rate will be honored until Monday, October 6.
Please be sure to identify yourselves as part of BIOCOM Investor Conference.
For additional information about the Hyatt Regency La Jolla, please visit: http://lajolla.hyatt.com/hyatt/hotels/index.jsp

Sponsorship

Opportunities to sponsor BIOCOM’s 2008 Investor Conference are still available.  Please click here to view the sponsorship prospectus.  If you have any questions regarding sponsorship, please contact Shaye Exner at shaye.exner@biocom.org.

If you have any further questions about the conference, please contact Valerie Sanderson at vsanderson@biocom.org or call 858-455-0300.